Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-19

Clinical Trial Update: Evaluation of Chitosan Scaffold and Mineral Trioxide Aggregate Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chitosan scaffold and mineral trioxide aggregate pulpotomy in mature permanent molars with irreversible pulpitis has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chitosan scaffold and mineral trioxide aggregate pulpotomy

Snippet

Sponsor: Nourhan M.Aly | Conditions: Pulpitis - Irreversible | Phase 2 | Status: COMPLETED